All corruption in China articles
-
Blog
Sir Andrew Witty successor named: GSK revisited
Tom Fox looks at Sir Andrew Witty’s career as chief executive of GlaxoSmithKline, as the CEO recently resigned and was replaced by Emma Walmsley.
Close menu
- Home
-
News
- Back to parent navigation item
- News
- National Compliance Officer Day 2025
- Accounting & Auditing
- AI
- AML
- Anti-Bribery
- Best Practices
- Boards & Shareholders
- Cryptocurrency and Digital Assets
- Culture
- ESG/Social Responsibility
- Ethics & Culture
- Europe
- Financial Services
- Internal Controls
- Regulatory Enforcement
- Regulatory Policy
- Risk Management
- Sanctions
- Surveys & Benchmarking
- Supply Chain
- Third Party Risk
- Whistleblowers
- Opinion
- Benchmarking
- Certification
- Events
- Research
- Awards
-
CW Connect
- Back to parent navigation item
- CW Connect
- Sign In
- Apply
- Membership
- Contact
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Info
- © 2025 Compliance Week
Site powered by Webvision Cloud